eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients

Enrolling by invitation

Phase 2 Results N/A

Update History

3 Sep '16
The eligibility criteria were updated.
New
Inclusion Criteria: - Primary care patients - Age ≥ 50 years - Current depressive disorder - Elevated CVD risk Exclusion Criteria: - History of clinical cardiovascular disease - Presence of the following chronic disorders: HIV/AIDS, chronic kidney disease, systemic inflammatory disease, or past-year cancer - History of bipolar disorder or psychosis - Continuous (e.g., daily) treatment for a systemic inflammatory condition (e.g., rheumatoid arthritis, lupus, Crohn's disease, and ulcerative colitis) in the past 3 months. Nonsteroidal anti-inflammatory drug (NSAID) use is allowed, given its high prevalence in the target population. - • Current use of anticoagulants (Aspirin and cholesterol and blood pressure medications are allowed) - Acute risk of suicide - Severe cognitive impairment - Current pregnancy - Ongoing depression treatment with a psychiatrist outside of the Eskenazi Health/Midtown system (ongoing depression treatment with a Eskenazi Health/Midtown psychiatrist is allowed, as we will be able to collaborate and coordinate depression care)
Old
Inclusion Criteria: - Primary care patients - Age ≥ 50 years - Current depressive disorder - Elevated CVD risk Exclusion Criteria: - History of clinical cardiovascular disease - Presence of the following chronic disorders: HIV/AIDS, chronic kidney disease, systemic inflammatory disease, or past-year cancer - History of bipolar disorder or psychosis - Current use of anticoagulants or vasodilators (cholesterol and blood pressure medications are allowed) - Acute risk of suicide - Severe cognitive impairment - Current pregnancy - Ongoing depression treatment with a psychiatrist
14 Aug '15
A location was updated in Indianapolis.
New
The overall status was removed for IUPUI Department of Psychology.